Truvestments Capital’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-52
| Closed | -$170 | – | 975 |
|
|
2022
Q4 | $170 | Hold |
52
| – | – | ﹤0.01% | 900 |
|
|
2022
Q3 | $0 | Sell |
52
-12
| -19% | -$41 | ﹤0.01% | 674 |
|
|
2022
Q2 | $0 | Buy |
+64
| New | +$297 | ﹤0.01% | 660 |
|
|
2022
Q1 | – | Sell |
-65
| Closed | -$1K | – | 612 |
|
|
2021
Q4 | $1K | Hold |
65
| – | – | ﹤0.01% | 598 |
|
|
2021
Q3 | $3K | Hold |
65
| – | – | ﹤0.01% | 526 |
|
|
2021
Q2 | $3K | Hold |
65
| – | – | ﹤0.01% | 536 |
|
|
2021
Q1 | $3K | Buy |
65
+24
| +59% | +$1.4K | ﹤0.01% | 601 |
|
|
2020
Q4 | $4K | Buy |
+41
| New | +$3.59K | ﹤0.01% | 517 |
|
|
2020
Q3 | – | Sell |
-41
| Closed | -$4K | – | 599 |
|
|
2020
Q2 | $4K | Buy |
+41
| New | +$4.87K | ﹤0.01% | 480 |
|
|
2019
Q4 | – | Sell |
-73
| Closed | -$4K | – | 658 |
|
|
2019
Q3 | $4K | Sell |
73
-5
| -6% | -$400 | ﹤0.01% | 617 |
|
|
2019
Q2 | $6K | Hold |
78
| – | – | ﹤0.01% | 607 |
|
|
2019
Q1 | $10K | Buy |
+78
| New | +$8.19K | 0.01% | 525 |
|
|
2018
Q3 | $9K | Buy |
+83
| New | +$7.9K | ﹤0.01% | 667 |
|
Other funds holding CALA
Truvestments Capital's CALA Position: Q1 2023 in Review
Truvestments Capital sold out of Calithera Biosciences, Inc (CALA) in Q1 2023, closing a stake of 52 shares — an estimated $170 sold.
Truvestments Capital first reported a position in CALA in Q3 2018 and held it in 13 quarters. The position peaked at $10K in Q1 2019. 2 funds tracked by Wall St. Rank hold CALA as of Q1 2023.
- Truvestments Capital reported no remaining Calithera Biosciences, Inc position as of Q1 2023 after selling out during the quarter.
- Truvestments Capital sold 52 Calithera Biosciences, Inc shares in Q1 2023, an estimated $170.
- Truvestments Capital first reported a position in Calithera Biosciences, Inc in Q3 2018 and held it in 13 quarters.
- Truvestments Capital's Calithera Biosciences, Inc position peaked at $10K in Q1 2019.
- 2 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2023.
Based on Truvestments Capital's 13F filing for Q1 2023, filed 12 May 2023.